IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus.
Pemphigus is a group of autoimmune blistering diseases of the skin and mucous membranes. In human patients with pemphigus vulgaris (PV) and paraneoplastic pemphigus (PNP), IgG autoantibodies against desmoglein (Dsg) 3 and Dsg1 play pathogenic roles in blister formation. In contrast, the target for IgG autoantibodies that induce keratinocyte dissociation has not been elucidated in canine pemphigus. The aim of the present study was to determine whether anti-Dsg IgG autoantibodies are present and disrupt the cell-cell adhesion of keratinocytes in canine PV and PNP. The extracellular domains of canine Dsg3 were recognized by IgG in 3/5 (60%) canine PV sera tested. IgG against the extracellular domains of canine Dsg1 was detected exclusively in two dogs that had PV with the mucocutaneous phenotype. In addition, anti-Dsg3 IgG was identified in canine PNP serum. Furthermore, incubation of normal human keratinocytes (NHK) with mucocutaneous canine PV serum and canine PNP serum resulted in dissociation of the NHK sheets, whereas the removal of anti-Dsg3 IgG from these canine sera blocked this dissociation. The present study indicates for the first time that circulating anti-Dsg3 IgG antibodies capable of dissociating keratinocytes are present in dogs with PV and PNP.
Nishifuji
Koji
K
Department of Dermatology, Keio University School of Medicine, 35 Shinanomachi, Tokyo 160-8582, Japan. kojimail@sc.itc.keio.ac.jp
Olivry
Thierry
T
Ishii
Ken
K
Iwasaki
Toshiroh
T
Amagai
Masayuki
M
D000818:Animals; D001323:Autoantibodies / Q000276:immunology* / Q000378:metabolism; D002448:Cell Adhesion; D002460:Cell Line; D051183:Desmoglein 1 / Q000276:immunology / Q000378:metabolism; D051184:Desmoglein 3 / Q000276:immunology / Q000378:metabolism; D004283:Dog Diseases / Q000276:immunology* / Q000503:physiopathology; D004285:Dogs; D015151:Immunoblotting; D007150:Immunohistochemistry; D015603:Keratinocytes / Q000187:drug effects / Q000276:immunology*; D010257:Paraneoplastic Syndromes / Q000276:immunology / Q000503:physiopathology / Q000662:veterinary*; D010392:Pemphigus / Q000209:etiology / Q000276:immunology / Q000503:physiopathology / Q000662:veterinary*; D011994:Recombinant Proteins
D001323:Autoantibodies; D051183:Desmoglein 1; D051184:Desmoglein 3; D011994:Recombinant Proteins